<?xml version="1.0" encoding="UTF-8"?>
<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema"
              xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema"
              xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema"
              xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
              xmlns:dct="http://purl.org/dc/terms/"
              xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
              xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/"
              xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/"
              xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/"
              xmlns:cja="http://www.elsevier.com/xml/cja/schema"
              xmlns:ja="http://www.elsevier.com/xml/ja/schema"
              xmlns:bk="http://www.elsevier.com/xml/bk/schema"
              xmlns:ce="http://www.elsevier.com/xml/common/schema"
              xmlns:mml="http://www.w3.org/1998/Math/MathML"
              xmlns:cals="http://www.elsevier.com/xml/common/cals/schema"
              xmlns:tb="http://www.elsevier.com/xml/common/table/schema"
              xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema"
              xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema"
              xmlns:xlink="http://www.w3.org/1999/xlink">
   <rdf:RDF>
      <rdf:Description rdf:about="http://dx.doi.org/10.1016/j.bbadva.2021.100030">
         <dct:format>application/xml</dct:format>
         <dct:title>Leading individual features of antioxidant systematically classified by the ORAC assay and its single electron transfer and hydrogen atom transfer reactivities; analyzing ALS therapeutic drug Edaravone</dct:title>
         <dct:creator>Miwa Takatsuka</dct:creator>
         <dct:creator>Satoru Goto</dct:creator>
         <dct:creator>Kenshiro Kobayashi</dct:creator>
         <dct:creator>Yuta Otsuka</dct:creator>
         <dct:creator>Yohsuke Shimada</dct:creator>
         <dct:subject>
            <rdf:Bag>
               <rdf:li>Anti-radical activity</rdf:li>
               <rdf:li>Antioxidant</rdf:li>
               <rdf:li>Voronoi polyhedral division</rdf:li>
               <rdf:li>ORAC analysis</rdf:li>
               <rdf:li>Edaravone</rdf:li>
            </rdf:Bag>
         </dct:subject>
         <dct:description>BBA Advances 1 (2021). doi:10.1016/j.bbadva.2021.100030</dct:description>
         <prism:aggregationType>journal</prism:aggregationType>
         <prism:publicationName>BBA Advances</prism:publicationName>
         <prism:copyright>© 2021 The Authors. Published by Elsevier B.V.</prism:copyright>
         <dct:publisher>Elsevier B.V.</dct:publisher>
         <prism:issn>2667-1603</prism:issn>
         <prism:volume>1</prism:volume>
         <prism:coverDisplayDate>2021</prism:coverDisplayDate>
         <prism:doi>10.1016/j.bbadva.2021.100030</prism:doi>
         <prism:url>http://dx.doi.org/10.1016/j.bbadva.2021.100030</prism:url>
         <dct:identifier>doi:10.1016/j.bbadva.2021.100030</dct:identifier>
         <bam:articleNumber>100030</bam:articleNumber>
         <oa:openAccessInformation>
            <oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus>
            <oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-10-27T12:26:14Z</oa:openAccessEffective>
            <oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
               <oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType>
            </oa:sponsor>
            <oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense>
         </oa:openAccessInformation>
         <cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine>
      </rdf:Description>
   </rdf:RDF>
   <dp:document-properties>
      <dp:aggregation-type>Journals</dp:aggregation-type>
      <dp:version-number>S300.1</dp:version-number>
   </dp:document-properties>
   <ja:article docsubtype="fla" version="5.6" xml:lang="en">
      <ja:item-info>
         <ja:jid>BBADVA</ja:jid>
         <ja:aid>100030</ja:aid>
         <ce:article-number>100030</ce:article-number>
         <ce:pii>S2667-1603(21)00029-6</ce:pii>
         <ce:doi>10.1016/j.bbadva.2021.100030</ce:doi>
         <ce:copyright type="unknown" year="2021"/>
      </ja:item-info>
      <ja:head>
         <ce:title id="tte0002">Leading individual features of antioxidant systematically classified by the ORAC assay and its single electron transfer and hydrogen atom transfer reactivities; analyzing ALS therapeutic drug Edaravone</ce:title>
         <ce:author-group id="aut0001">
            <ce:author id="au0001"
                       author-id="S2667160321000296-b2b78d1840b731b7f89819e69ba7bf42">
               <ce:given-name>Miwa</ce:given-name>
               <ce:surname>Takatsuka</ce:surname>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0002"
                       author-id="S2667160321000296-8c7c50958e7329d55b4989559ad58399">
               <ce:given-name>Satoru</ce:given-name>
               <ce:surname>Goto</ce:surname>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="cor0001">
                  <ce:sup loc="post">⁎</ce:sup>
               </ce:cross-ref>
               <ce:e-address id="ead0001" type="email" xlink:href="mailto:s.510@rs.tus.ac.jp">s.510@rs.tus.ac.jp</ce:e-address>
            </ce:author>
            <ce:author id="au0003"
                       author-id="S2667160321000296-f853b689156905eea60ded91c7219559">
               <ce:given-name>Kenshiro</ce:given-name>
               <ce:surname>Kobayashi</ce:surname>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0004"
                       author-id="S2667160321000296-6a7b14a8d6290f784736349c6cd8c4f8">
               <ce:given-name>Yuta</ce:given-name>
               <ce:surname>Otsuka</ce:surname>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0005"
                       author-id="S2667160321000296-b528f5db23717bb0b767acd945784b75">
               <ce:given-name>Yohsuke</ce:given-name>
               <ce:surname>Shimada</ce:surname>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0002">
                  <ce:sup loc="post">b</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:affiliation id="aff0001"
                            affiliation-id="S2667160321000296-3fabbeb51ae2331b71f7284ca31b5959">
               <ce:label>a</ce:label>
               <ce:textfn id="cetextfn0001">Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Faculty of Pharmaceutical Sciences</sa:organization>
                  <sa:organization>Tokyo University of Science, 2641 Yamazaki</sa:organization>
                  <sa:city>Noda</sa:city>
                  <sa:state>Chiba</sa:state>
                  <sa:postal-code>278-8510</sa:postal-code>
                  <sa:country>Japan</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0001">aFaculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff0002"
                            affiliation-id="S2667160321000296-7a3eb60c26c7275cf6e2f1e8f3515c9a">
               <ce:label>b</ce:label>
               <ce:textfn id="cetextfn0002">PFF Co.,Ltd, 4-3-9 Konandai Konan-ku, Yokohama, Kanagawa, 234-0054, Japan</ce:textfn>
               <sa:affiliation>
                  <sa:organization>PFF Co.,Ltd, 4-3-9 Konandai Konan-ku</sa:organization>
                  <sa:city>Yokohama</sa:city>
                  <sa:state>Kanagawa,</sa:state>
                  <sa:postal-code>234-0054</sa:postal-code>
                  <sa:country>Japan</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0002">bPFF Co.,Ltd, 4-3-9 Konandai Konan-ku, Yokohama, Kanagawa, 234-0054, Japan</ce:source-text>
            </ce:affiliation>
            <ce:correspondence id="cor0001">
               <ce:label>⁎</ce:label>
               <ce:text id="cetext0001">Corresponding author.</ce:text>
            </ce:correspondence>
         </ce:author-group>
         <ce:date-received day="28" month="6" year="2021"/>
         <ce:date-revised day="20" month="10" year="2021"/>
         <ce:date-accepted day="27" month="10" year="2021"/>
         <ce:abstract id="abs0001" class="author-highlights" view="all">
            <ce:section-title id="cesectitle0001">Highlights</ce:section-title>
            <ce:abstract-sec id="abss0001" view="all">
               <ce:simple-para id="spara008" view="all">
                  <ce:list id="celist0001">
                     <ce:list-item id="celistitem0001">
                        <ce:label>•</ce:label>
                        <ce:para id="para0001" view="all">We attempted to classify antioxidants by separately analyzing the two steps of the SET process of peroxide radical generation in the ORAC assay and the HAT process that competes with fluorescein.</ce:para>
                     </ce:list-item>
                     <ce:list-item id="celistitem0002">
                        <ce:label>•</ce:label>
                        <ce:para id="para0002" view="all">Analysis using cysteine, ascorbic acid, trolox, and BHT as criteria for comparison concluded that edaravone belongs to the same group as cysteine.</ce:para>
                     </ce:list-item>
                     <ce:list-item id="celistitem0003">
                        <ce:label>•</ce:label>
                        <ce:para id="para0003" view="all">The close relationship of edaravone with cysteine provides important in the search for ALS therapeutics.</ce:para>
                     </ce:list-item>
                  </ce:list>
               </ce:simple-para>
            </ce:abstract-sec>
         </ce:abstract>
         <ce:abstract id="abs0002" view="all" class="author">
            <ce:section-title id="cesectitle0002">Abstract</ce:section-title>
            <ce:abstract-sec id="abss0002" view="all">
               <ce:simple-para id="spara009" view="all">Many natural compounds mop up radicals and limit radical reactions and may prove useful in reducing or preventing oxidative stress-related diseases in vivo. Several assays have been developed to measure antioxidant or anti-radical activity. Here, we measured the anti-radical activities of representative antioxidants using different assays. The oxygen radical absorption capacity (ORAC) assay has two mechanistic stages. We classified antioxidant behavior using two characteristic values thought to be related to the two stages — peroxyl radical formation time (lag time) and fluorescein annihilation rate (<ce:italic>k</ce:italic>
                  <ce:inf loc="post">obs</ce:inf>) — by applying Voronoi polyhedral division. We focused on four class-representative antioxidants, Trolox ®, vitamin C, <ce:small-caps>l</ce:small-caps>-cysteine, and 2,6-di‑<ce:italic>tert</ce:italic>‑butyl‑<ce:italic>p</ce:italic>-cresol, and compared their characteristic activities with those of edaravone. Our analysis indicates that edaravone is in the same group as cysteine and may function via a similar mechanism. Our results suggest that analyzing lag time and <ce:italic>k</ce:italic>
                  <ce:inf loc="post">obs</ce:inf> is a useful method to characterize antioxidants.</ce:simple-para>
            </ce:abstract-sec>
         </ce:abstract>
         <ce:abstract id="abs0003" class="graphical" view="all">
            <ce:section-title id="cesectitle0003">Graphic abstract</ce:section-title>
            <ce:abstract-sec id="abss0003" view="all">
               <ce:simple-para id="spara010" view="all"> [Display omitted] </ce:simple-para>
               <ce:simple-para id="spara011" view="all">Single electron transfer and hydrogen atom transfer reactivity in the oxygen radical absorption capacity assay of class representative antioxidants and edaravone</ce:simple-para>
            </ce:abstract-sec>
         </ce:abstract>
         <ce:keywords id="keys0001" view="all" class="keyword">
            <ce:section-title id="cesectitle0004">Keywords</ce:section-title>
            <ce:keyword id="key0001">
               <ce:text id="cetext0002">Anti-radical activity</ce:text>
            </ce:keyword>
            <ce:keyword id="key0002">
               <ce:text id="cetext0003">Antioxidant</ce:text>
            </ce:keyword>
            <ce:keyword id="key0003">
               <ce:text id="cetext0004">Voronoi polyhedral division</ce:text>
            </ce:keyword>
            <ce:keyword id="key0004">
               <ce:text id="cetext0005">ORAC analysis</ce:text>
            </ce:keyword>
            <ce:keyword id="key0005">
               <ce:text id="cetext0006">Edaravone</ce:text>
            </ce:keyword>
         </ce:keywords>
      </ja:head>
   </ja:article>
</doc:document>
